Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Hansoh Pharmaceutical Group Company Limited (HK:3692)

HKEX:3692

3692

Hansoh Pharmaceutical Group Company Limited

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding HK:3692?

Track your performance easily

Link Broker

Hansoh Pharmaceutical Group Company Limited (3692) Stock Price & Analysis

1 Followers

3692 Stock Chart & Stats

Advanced Chart >

Day’s RangeHK$0 - HK$0

52-Week RangeHK$11.18 - HK$22.80

Previous CloseHK$17.86

Volume10.54M

Average Volume (3M)8.90M

Market Cap

HK$101.86B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)19.9

Beta0.98

Next Earnings

Apr 01, 2025

EPS Estimate

HK$0.24

Last Dividend Ex-Date

Sep 20, 2024

Dividend Yield2%

Share Statistics

EPS (TTM)0.86

Shares OutstandingN/A

10 Day Avg. Volume6,523,819

30 Day Avg. Volume8,902,844

Standard Deviation0.12

R-Squared0.21

Alpha0.00531

Financial Highlights & Ratios

Price to Book (P/B)0.00

Price to Sales (P/S)7.43

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$24.61

Price Target Upside37.79% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

Hansoh Pharmaceutical Group Company Limited News

PremiumCompany Announcements

Hansoh Pharma’s Breakthrough in Cancer Drug Development

21d ago

3692

PremiumCompany Announcements

Hansoh Pharma’s Ameile Achieves Key Trial Success

1M ago

3692

PremiumDividends

Hansoh Pharmaceutical Group Company Limited (3692) Unveils Dividend Details for Q4: Mark Your Calendar!

3M ago

3692

PremiumCompany Announcements

Hansoh Pharma Announces Mid-Year Dividend

3M ago

3692

PremiumCompany Announcements

Hansoh Pharmaceutical Reports Soaring H1 2024 Profits

3M ago

3692

PremiumCompany Announcements

Hansoh Pharma’s Cancer Drug Fast-Tracked by FDA

3M ago

3692

PremiumCompany Announcements

Hansoh Pharmaceutical’s New Drug Application Accepted

3M ago

3692

PremiumCompany Announcements

Hansoh Pharmaceutical Plans Key Board Meeting

3M ago

3692

See More HK:3692 News >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

2.68% Mutual Funds

― Other Institutional Investors

95.48% Public Companies and

Individual Investors

Detailed Ownership Overview >

3692 FAQ

What was Hansoh Pharmaceutical Group Company Limited’s price range in the past 12 months?

Hansoh Pharmaceutical Group Company Limited lowest stock price was HK$11.18 and its highest was HK$22.80 in the past 12 months.

What is Hansoh Pharmaceutical Group Company Limited’s market cap?

Currently, no data Available

When is Hansoh Pharmaceutical Group Company Limited’s upcoming earnings report date?

Hansoh Pharmaceutical Group Company Limited’s upcoming earnings report date is Apr 01, 2025 which is in 130 days.

How were Hansoh Pharmaceutical Group Company Limited’s earnings last quarter?

Hansoh Pharmaceutical Group Company Limited released its earnings results on Aug 27, 2024. The company reported HK$0.494 earnings per share for the quarter, beating the consensus estimate of HK$0.419 by HK$0.075.

Is Hansoh Pharmaceutical Group Company Limited overvalued?

According to Wall Street analysts Hansoh Pharmaceutical Group Company Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Hansoh Pharmaceutical Group Company Limited pay dividends?

Hansoh Pharmaceutical Group Company Limited pays a Annually dividend of HK$0.2 which represents an annual dividend yield of 2%. See more information on Hansoh Pharmaceutical Group Company Limited dividends here

What is Hansoh Pharmaceutical Group Company Limited’s EPS estimate?

Hansoh Pharmaceutical Group Company Limited’s EPS estimate is HK$0.24.

How many shares outstanding does Hansoh Pharmaceutical Group Company Limited have?

Hansoh Pharmaceutical Group Company Limited has 5,935,650,000 shares outstanding.

What happened to Hansoh Pharmaceutical Group Company Limited’s price movement after its last earnings report?

Hansoh Pharmaceutical Group Company Limited reported an EPS of HK$0.494 in its last earnings report, beating expectations of HK$0.419. Following the earnings report the stock price went up 1.348%.

Which hedge fund is a major shareholder of Hansoh Pharmaceutical Group Company Limited?

Currently, no hedge funds are holding shares in HK:3692

---

Hansoh Pharmaceutical Group Company Limited Stock Smart Score

Unlock Smart Score

Analyst Consensus

Strong Buy

Average Price Target:
HK$24.61 (37.79% Upside)

Technicals

Fundamentals

Return on Equity

18.20%

Trailing 12-Months

Asset Growth

-1.24%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified, and leading drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on the gastrointestinal and cardiovascular therapeutic areas.

---

3692 Stock 12 Month Forecast

Average Price Target

HK$24.61

▲(37.79% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"HK$12","31":"HK$31","16.75":"HK$16.75","21.5":"HK$21.5","26.25":"HK$26.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$24.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$17.95</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,16.75,21.5,26.25,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.84,18.775384615384617,19.71076923076923,20.646153846153847,21.58153846153846,22.516923076923078,23.45230769230769,24.38769230769231,25.323076923076922,26.25846153846154,27.193846153846152,28.12923076923077,29.064615384615387,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.84,18.36076923076923,18.88153846153846,19.40230769230769,19.923076923076923,20.443846153846152,20.964615384615385,21.485384615384614,22.006153846153847,22.526923076923076,23.04769230769231,23.568461538461538,24.089230769230767,{"y":24.61,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.84,17.84846153846154,17.856923076923078,17.865384615384617,17.873846153846152,17.88230769230769,17.89076923076923,17.89923076923077,17.907692307692308,17.916153846153847,17.924615384615382,17.93307692307692,17.94153846153846,{"y":17.95,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.38,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.41,"date":1700179200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.59,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.67,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.04,"date":1710460800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":15.57,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.91,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.5,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.47,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.47,"date":1722556800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.68,"date":1725580800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.6,"date":1728000000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.84,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >

Technical Analysis

Similar Stocks

CStone Pharmaceuticals

―

1167

Jacobio Pharmaceuticals Group Co., Ltd.

―

Compare HK:3692 Stocks >

Best Analysts Covering 3692

1 Year

Linda ShuHSBC

1 Year Success Rate

3/3 ratings generated profit

1 Year Average Return

+62.47%

reiterated a buy rating 8 months ago

Copying Linda Shu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +62.47% per trade.

Best Analyst Covering >

Popular Stocks

---

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing